Europe Readies For Big Changes In Device Post-Market Surveillance
This article was originally published in SRA
Efforts to strengthen post-market surveillance activities for medical devices in the EU are picking up steam as the region tries to address gaps identified in the wake of the Poly Implant Prothèse (PIP) affair.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.